Bayer Invests 2.2 Billion in US Pharma Site
Bayer plans to invest 2.2 billion dollars in a new manufacturing site in Ohio to boost its US pharmaceutical revenue. The expansion aims to support key products and create hundreds of new jobs.
Xurve View
Insights:
Xurve View
Bayer AG will invest $2.2B in a new manufacturing site in New Albany, Ohio, targeting a doubling of its United States revenue by the end of the decade. The investment marks a strategic expansion for the Germany-based drugmaker as it scales up its prescription medicine footprint. The expansion aims to capture higher domestic market share despite ongoing pricing pressures from Washington.
